BrainSignsLab - Plasma biomarkers in relation to spatial distribution

Journal article

Murat Bilgel, Ishaan Shah, Keenan A. Walker, A. Moghekar, N. Ashton, P. Kac, T. Karikari, K. Blennow, Henrik Zetterberg, M. Thambisetty, L. Ferrucci, Susan M. Resnick
Alzheimer's & Dementia, 2023

Semantic Scholar DOI

Cite

APA Click to copy
Bilgel, M., Shah, I., Walker, K. A., Moghekar, A., Ashton, N., Kac, P., … Resnick, S. M. (2023). Plasma biomarkers in relation to spatial distribution of Alzheimer’s disease neuropathology. Alzheimer's &Amp;Amp; Dementia.

Chicago/Turabian Click to copy
Bilgel, Murat, Ishaan Shah, Keenan A. Walker, A. Moghekar, N. Ashton, P. Kac, T. Karikari, et al. “Plasma Biomarkers in Relation to Spatial Distribution of Alzheimer’s Disease Neuropathology.” Alzheimer's & Dementia (2023).

MLA Click to copy
Bilgel, Murat, et al. “Plasma Biomarkers in Relation to Spatial Distribution of Alzheimer’s Disease Neuropathology.” Alzheimer's &Amp;Amp; Dementia, 2023.

BibTeX Click to copy

@article{murat2023a,
  title = {Plasma biomarkers in relation to spatial distribution of Alzheimer’s disease neuropathology},
  year = {2023},
  journal = {Alzheimer's &amp; Dementia},
  author = {Bilgel, Murat and Shah, Ishaan and Walker, Keenan A. and Moghekar, A. and Ashton, N. and Kac, P. and Karikari, T. and Blennow, K. and Zetterberg, Henrik and Thambisetty, M. and Ferrucci, L. and Resnick, Susan M.}
}

Abstract

The clinical utility of plasma biomarkers will in part be based on the information they convey regarding the distribution of neuropathology, especially beyond the information provided by demographics. We examined the associations of plasma biomarkers with cerebral amyloid and tau pathology determined by positron emission tomography (PET).